• Jordan Thygesen posted an update 2 months ago

    The nanohybrids are quite stable for days, even in aqueous solutions mimicking physiological medium (NaCl 0.15 M). This property, together with their peculiar optical features in the therapeutic window of visible spectrum, make them potentially useful for biomedical applications.Graphene shows great potential applications in functional coating, electrodes, and ultrasensitive sensors, but high-yield and scalable preparation of few-layer graphene (FLG) by mechanical exfoliation method is still a formidable challenge. In this work, a novel two-step method for high-yield preparation of FLG is developed by combining resonance ball milling and hydrothermal treatment. During the resonance ball milling process, the utilization of magnetic Fe3O4 nanoparticles as a new “particle wedge” is beneficial to facilitate fragment and delamination of graphitic layers. In addition, further hydrothermal treatment can enhance ball milling product (BMP) exfoliation because of the shear force driven by the Brownian motion of various molecules at high temperature and high pressure. As expected, the two-step method can have high exfoliation efficiency up to 92% (≤10 layers). Moreover, the FLG nanosheet ink can easily achieve the formation of FLG coatings on the surface of various substrates, resulting in good electrical conductivity, which possesses potential applications in various fields including functional coating, energy storages, and electrochemical sensors, etc. Our work provides a new-fashioned strategy for mechanical large-scale production of graphene.Dysregulated metabolism of homocysteine (Hcy) is associated with obesity. Supplementation with probiotics can potentially be a natural therapeutic method for metabolic disorders. The precise mechanism in which microbiota affect Hcy metabolism in obese individuals is still unknown. The aim of this study was to evaluate the effects of a 12-week supplementation with a multispecies probiotic on Hcy levels, oxidative stress, inflammation and lipid profile in obese patients. This randomized double-blind placebo-controlled trial was performed on 50 obese women (aged 45-70 years). Subjects were randomly assigned to take either a multispecies probiotic supplement (n = 25) or placebo (n = 25) for 12 weeks. The probiotic contained nine bacterial strains containing 2.5 × 109 CFU/g. selleck chemicals Biochemical and anthropometric measurements were carried out at baseline and after 12 weeks of intervention. At the end of the study, a significant decrease in Hcy, tumor necrosis factor α (TNF-α), total cholesterol (TC), low-density lipoprotein cholesterol (LDL) and triglyceride (TG) levels were observed in the probiotic group. The amelioration of total antioxidant status (TAS) was also observed. The 12-week supplementation of the multispecies probiotic (Ecologic® BARIER) effectively reduced Hcy concentration, oxidative stress and inflammation, and improved the lipid profile. These multidirectional effects can potentially reduce cardiometabolic risks.Liveweight gain of lambs weaned early at a minimum live weight of 14 kg, at ~50 days of age, onto a herb-clover mix was compared with lambs that remained unweaned on a grass-predominant pasture or a herb-clover mix until conventional weaning (at ~99 days of age). Over two years, twin sets of lambs that had a minimum live weight of 14 kg were randomly allocated to one of three treatments (1) Early weaning of lambs onto a herb-clover mix (HerbEW); (2) ewes and lambs grazing a herb-clover mix until conventional weaning (HerbCW); and (3) ewes and lambs grazing a grass-predominant pasture until conventional weaning (GrassCW). HerbEW lambs had slower (p 0.05) in live weight at conventional weaning. HerbCW lambs had a greater (p less then 0.05) growth rates than both HerbEW and GrassCW lambs in both years. Lambs weaned early onto a herb-clover mix have the potential to achieve live weights similar to lambs unweaned on grass-predominant pasture. Further research, however, is required to understand conditions under which early-weaned lambs can achieve similar live weights.Lung cancer (LC) cells frequently express high levels of programmed death-ligand 1 (PD-L1). Although these levels grossly correlate with the likelihood of response to specific checkpoint inhibitors, the response prediction is rather imperfect, and more accurate predictive biomarkers are mandatory. We examined the methylation profile of RAD51B (RAD51Bme) as a candidate predictive biomarker for anti-PD-1 therapy efficacy in non-small cell lung cancer (NSCLC), correlating with patients’ outcome. PD-L1 immunoexpression and RAD51Bme levels were analysed in NSCLC samples obtained from patients not treated with anti-PD-1 (Untreated Cohort (#1)) and patients treated with PD-1 blockade (Treated Cohort (#2)). Of a total of 127 patients assessed, 58.3% depicted PD-L1 positivity (PD-L1+). RAD51Bme levels were significantly associated with PD-L1 immunoexpression. Patients with PD-1 blockade clinical benefit disclosed higher RAD51Bme levels (p = 0.0390) and significantly lower risk of disease progression (HR 0.37; 95% CI 0.15-0.88; p = 0.025). Combining RAD51Bme+ with PD-L1+ improved the sensitivity of the test to predict immunotherapy response. PD-L1+ was also associated with lower risk of death (HR 0.35; 95% CI 0.15-0.81; p = 0.014). Thus, RAD51Bme levels might be combined with validated predictive biomarker PD-L1 immunostaining to select patients who will most likely experience clinical benefit from PD-1 blockade. The predictive value of RAD51Bme should be confirmed in prospective studies.The Genomics of Malignant Peripheral Nerve Sheath Tumor (GeM) Consortium is an international collaboration focusing on multi-omic analysis of malignant peripheral nerve sheath tumors (MPNSTs), the most aggressive tumor associated with neurofibromatosis type 1 (NF1). Here we present a summary of current knowledge gaps, a description of our consortium and the cohort we have assembled, and an overview of our plans for multi-omic analysis of these tumors. We propose that our analysis will lead to a better understanding of the order and timing of genetic events related to MPNST initiation and progression. Our ten institutions have assembled 96 fresh frozen NF1-related (63%) and sporadic MPNST specimens from 86 subjects with corresponding clinical and pathological data. Clinical data have been collected as part of the International MPNST Registry. We will characterize these tumors with bulk whole genome sequencing, RNAseq, and DNA methylation profiling. In addition, we will perform multiregional analysis and temporal sampling, with the same methodologies, on a subset of nine subjects with NF1-related MPNSTs to assess tumor heterogeneity and cancer evolution.

All content contained on CatsWannaBeCats.Com, unless otherwise acknowledged,is the property of CatsWannaBeCats.Com and subject to copyright.

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

or    

Forgot your details?

Create Account